ProQR Therapeutics N.V. Quarterly General And Administrative Expense in EUR from Q2 2017 to Q4 2023

Taxonomy & unit
ifrs-full: EUR
Summary
ProQR Therapeutics N.V. quarterly/annual General And Administrative Expense history and growth rate from Q2 2017 to Q4 2023.
  • ProQR Therapeutics N.V. General And Administrative Expense for the quarter ending December 31, 2023 was €4.75M, a 59.8% increase year-over-year.
  • ProQR Therapeutics N.V. General And Administrative Expense for the twelve months ending December 31, 2023 was €16.2M, a 12.9% decline year-over-year.
  • ProQR Therapeutics N.V. annual General And Administrative Expense for 2023 was €16.2M, a 12.9% decline from 2022.
  • ProQR Therapeutics N.V. annual General And Administrative Expense for 2022 was €18.7M, a 7.39% increase from 2021.
  • ProQR Therapeutics N.V. annual General And Administrative Expense for 2021 was €17.4M, a 26.9% increase from 2020.
General And Administrative Expense, Trailing 12 Months (EUR)
General And Administrative Expense, Quarterly (EUR)
General And Administrative Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2023 16.2M 4.75M +1.78M +59.8% Oct 1, 2023 Dec 31, 2023 20-F 2024-03-13
Q3 2023 14.5M 3.32M -2.04M -38.1% Jul 1, 2023 Sep 30, 2023 6-K 2023-11-07
Q2 2023 16.5M 4.15M -1.27M -23.4% Apr 1, 2023 Jun 30, 2023 6-K 2023-08-03
Q1 2023 17.8M 4.03M -882K -18% Jan 1, 2023 Mar 31, 2023 6-K 2023-05-16
Q4 2022 18.7M 2.97M -2.34M -44.1% Oct 1, 2022 Dec 31, 2022 20-F 2024-03-13
Q3 2022 21M 5.36M +768K +16.7% Jul 1, 2022 Sep 30, 2022 6-K 2023-11-07
Q2 2022 20.2M 5.41M +1.29M +31.3% Apr 1, 2022 Jun 30, 2022 6-K 2023-08-03
Q1 2022 18.9M 4.91M +1.57M +47% Jan 1, 2022 Mar 31, 2022 6-K 2023-05-16
Q4 2021 17.4M 5.32M +1.8M +51.4% Oct 1, 2021 Dec 31, 2021 6-K 2022-02-24
Q3 2021 15.6M 4.59M +1.78M +63.4% Jul 1, 2021 Sep 30, 2021 6-K 2022-11-09
Q2 2021 13.8M 4.12M +676K +19.6% Apr 1, 2021 Jun 30, 2021 6-K 2022-08-04
Q1 2021 13.1M 3.34M -579K -14.8% Jan 1, 2021 Mar 31, 2021 6-K 2022-05-05
Q4 2020 13.7M 3.51M -405K -10.3% Oct 1, 2020 Dec 31, 2020 6-K 2022-02-24
Q3 2020 14.1M 2.81M -94K -3.24% Jul 1, 2020 Sep 30, 2020 6-K 2021-11-04
Q2 2020 14.2M 3.45M +570K +19.8% Apr 1, 2020 Jun 30, 2020 6-K 2021-08-05
Q1 2020 13.6M 3.92M +727K +22.8% Jan 1, 2020 Mar 31, 2020 6-K 2020-05-07
Q4 2019 12.9M 3.92M Oct 1, 2019 Dec 31, 2019 6-K 2021-02-25
Q3 2019 2.9M +324K +12.6% Jul 1, 2019 Sep 30, 2019 6-K 2020-11-16
Q2 2019 2.88M +227K +8.57% Apr 1, 2019 Jun 30, 2019 6-K 2020-08-06
Q1 2019 3.19M Jan 1, 2019 Mar 31, 2019 6-K 2020-05-07
Q3 2018 2.58M Jul 1, 2018 Sep 30, 2018 6-K 2019-11-12
Q2 2018 2.65M -243K -8.4% Apr 1, 2018 Jun 30, 2018 6-K 2019-08-07
Q2 2017 2.89M Apr 1, 2017 Jun 30, 2017 6-K 2018-08-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.